8-K Announcements
6May 7, 2026·SEC
May 1, 2026·SEC
Mar 20, 2026·SEC
Reinsurance Group of America, Incorporated (RGA) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when RGA posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Reinsurance Group of America, Incorporated (RGA) stock price & volume — 10-year historical chart
Reinsurance Group of America, Incorporated (RGA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Reinsurance Group of America, Incorporated (RGA) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 7, 2026 | $6.97vs $6.03+15.6% | $6.5Bvs $6.5B+0.4% |
| Q1 2026 | Feb 5, 2026 | $7.75vs $5.78+34.1% | $6.6Bvs $6.3B+5.1% |
| Q4 2025 | Oct 30, 2025 | $6.37vs $5.76+10.6% | $6.2Bvs $6.1B+2.4% |
| Q3 2025 | Jul 31, 2025 | $4.72vs $5.58-15.4% | $5.6Bvs $6.0B-6.7% |
Reinsurance Group of America, Incorporated (RGA) competitors in Life and health reinsurers — business model, growth, and fundamentals comparison
Reinsurance Group of America, Incorporated (RGA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Reinsurance Group of America, Incorporated (RGA) annual income statement — 10-year revenue, gross profit & net income history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 12.52B | 12.88B | 14.2B | 14.58B | 16.06B | 15.88B | 18.39B | 22.04B | 22.79B | 24.59B |
Revenue Growth % | 8.63% | 2.88% | 10.27% | 2.71% | 10.13% | -1.13% | 15.82% | 19.85% | 3.39% | 17.29% |
Medical Costs & Claims | 10.49B | 11.07B | 12.1B | 13.04B | 14.21B | 14.31B | 16.06B | 19.55B | 17B | 19.59B |
Medical Cost Ratio % | 83.8% | 85.95% | 85.2% | 89.41% | 88.46% | 90.11% | 87.33% | 88.71% | 74.6% | 79.67% |
Gross Profit | 2.03B▲ 0% | 1.81B▼ 10.8% | 2.1B▲ 16.1% | 1.54B▼ 26.5% | 1.85B▲ 20.1% | 1.57B▼ 15.3% | 2.33B▲ 48.4% | 2.49B▲ 6.7% | 5.79B▲ 132.6% | 5B▲ 0% |
Gross Margin % | 16.2% | 14.05% | 14.8% | 10.59% | 11.54% | 9.89% | 12.67% | 11.29% | 25.4% | 20.33% |
Gross Profit Growth % | 9.45% | -10.8% | 16.14% | -26.51% | 20.08% | -15.26% | 48.38% | 6.74% | 132.64% | - |
Operating Expenses | 885M | 963M | 969M | 991M | 469M | 853M | 1.17B | 1.51B | 4.25B | 3.39B |
OpEx / Revenue % | 7.07% | 7.48% | 6.82% | 6.8% | 2.92% | 5.37% | 6.37% | 6.84% | 18.64% | 13.78% |
Depreciation & Amortization | 53M | 45M | 49M | 49M | 43M | 38M | 41M | 46M | 43M | 0 |
Combined Ratio % | 90.87% | 93.43% | 92.03% | 96.21% | 91.38% | 95.48% | 93.69% | 95.55% | 93.24% | 93.45% |
Operating Income | 1.14B▲ 0% | 846M▼ 26.0% | 1.13B▲ 33.8% | 553M▼ 51.1% | 1.39B▲ 150.5% | 718M▼ 48.2% | 1.16B▲ 61.6% | 980M▼ 15.5% | 1.54B▲ 57.1% | 1.61B▲ 0% |
Operating Margin % | 9.13% | 6.57% | 7.97% | 3.79% | 8.62% | 4.52% | 6.31% | 4.45% | 6.76% | 6.55% |
Operating Income Growth % | 9.49% | -25.98% | 33.81% | -51.15% | 150.45% | -48.16% | 61.56% | -15.52% | 57.14% | - |
EBITDA | 1.2B | 891M | 1.18B | 602M | 1.43B | 756M | 1.2B | 1.03B | 1.58B | 2B |
EBITDA Margin % | 9.56% | 6.92% | 8.32% | 4.13% | 8.89% | 4.76% | 6.53% | 4.65% | 6.95% | 8.12% |
Interest Expense | 146M | 147M | 173M | 170M | 139M | 191M | 257M | 304M | 366M | 386M |
Non-Operating Income | -146M | -147M | -173M | -170M | -139M | -191M | -257M | -304M | -366M | -386M |
Pretax Income | 1.14B▲ 0% | 846M▼ 26.0% | 1.13B▲ 33.8% | 553M▼ 51.1% | 1.39B▲ 150.5% | 718M▼ 48.2% | 1.16B▲ 61.6% | 980M▼ 15.5% | 1.54B▲ 57.1% | 1.61B▲ 0% |
Pretax Margin % | 9.13% | 6.57% | 7.97% | 3.79% | 8.62% | 4.52% | 6.31% | 4.45% | 6.76% | 6.55% |
Income Tax | -679M | 130M | 262M | 138M | 215M | 197M | 251M | 256M | 351M | 380M |
Effective Tax Rate % | -59.41% | 15.37% | 23.14% | 24.95% | 15.52% | 27.44% | 21.64% | 26.12% | 22.79% | 23.57% |
Net Income | 1.82B▲ 0% | 716M▼ 60.7% | 870M▲ 21.5% | 415M▼ 52.3% | 1.17B▲ 181.9% | 517M▼ 55.8% | 902M▲ 74.5% | 717M▼ 20.5% | 1.18B▲ 64.9% | 1.23B▲ 0% |
Net Margin % | 14.56% | 5.56% | 6.13% | 2.85% | 7.28% | 3.26% | 4.9% | 3.25% | 5.19% | 4.98% |
Net Income Growth % | 159.75% | -60.7% | 21.51% | -52.3% | 181.93% | -55.81% | 74.47% | -20.51% | 64.85% | 54.6% |
EPS (Diluted) | 27.71▲ 0% | 11.00▼ 60.3% | 13.62▲ 23.8% | 6.31▼ 53.7% | 9.04▲ 43.3% | 7.64▼ 15.5% | 13.44▲ 75.9% | 10.73▼ 20.2% | 17.69▲ 64.9% | 18.37▲ 0% |
EPS Growth % | 156.81% | -60.3% | 23.82% | -53.67% | 43.26% | -15.49% | 75.92% | -20.16% | 64.86% | 55.7% |
EPS (Basic) | 28.28 | 11.25 | 13.88 | 6.35 | 9.10 | 7.73 | 13.60 | 10.90 | 17.94 | - |
Diluted Shares Outstanding | 65.75M | 65.09M | 63.88M | 65.8M | 68.3M | 67.7M | 67.1M | 66.9M | 66.73M | 66.73M |
Reinsurance Group of America, Incorporated (RGA) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Assets | 60.51B | 64.54B | 76.73B | 84.66B | 92.17B | 84.9B | 97.62B | 118.67B | 156.59B | 164.06B |
Asset Growth % | 13.97% | 6.64% | 18.9% | 10.33% | 8.88% | -7.89% | 14.98% | 21.56% | 31.95% | 107.78% |
Total Investment Assets | 51.69B | 54.21B | 66.56B | 72.4B | 78.53B | 70.48B | 78.9B | 98.04B | 130.48B | 4M |
Long-Term Investments | 51.69B | 54.21B | 66.56B | 72.4B | 78.53B | 70.48B | 78.9B | 98.04B | 130.48B | 505B |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 3.64B | 4.91B | 4.39B | 6.25B | 5.84B | 5.94B | 6.5B | 7.22B | 8.64B | 9.25B |
Cash & Equivalents | 1.3B | 1.89B | 1.45B | 3.41B | 2.95B | 2.93B | 2.97B | 3.33B | 4.17B | 4.99B |
Receivables | 2.34B | 3.02B | 2.94B | 2.84B | 2.89B | 3.01B | 3.53B | 3.9B | 4.47B | 16.97B |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill & Intangibles | 204.8M | 40M | 33M | 25M | 12M | 14M | 11M | 8M | 6M | 6M |
Goodwill | 7M | 7M | 7M | 7M | 7M | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 197.8M | 33M | 26M | 18M | 5M | 14M | 11M | 8M | 6M | 0 |
PP&E (Net) | 302.2M | 302.1M | 296M | 291M | 284M | 408M | 416M | 450M | 480M | 0 |
Other Assets | 4.67B | 5.08B | 5.46B | 5.69B | 7.51B | 8.06B | 11.8B | 12.95B | 16.98B | 17.8B |
Total Liabilities | 50.95B | 56.08B | 65.13B | 70.3B | 79.16B | 77.73B | 88.45B | 107.77B | 143.04B | 150.68B |
Total Debt | 3.57B | 3.47B | 3.58B | 3.96B | 3.85B | 3.96B | 4.43B | 5.04B | 5.71B | 6.11B |
Net Debt | 2.27B | 1.58B | 2.13B | 553M | 899M | 1.03B | 1.46B | 1.72B | 1.54B | 1.11B |
Long-Term Debt | 3.57B | 3.47B | 3.58B | 3.96B | 3.85B | 3.96B | 4.43B | 5.04B | 5.71B | 6.11B |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 11.22B |
Other Liabilities | 45.17B | 50.82B | 58.84B | 63.08B | 72.43B | 72.39B | 82.16B | 100.53B | 134.33B | 141.39B |
Total Equity | 9.57B▲ 0% | 8.45B▼ 11.7% | 11.6B▲ 37.3% | 14.35B▲ 23.7% | 13.01B▼ 9.3% | 7.17B▼ 44.9% | 9.17B▲ 27.9% | 10.91B▲ 18.9% | 13.55B▲ 24.3% | 13.38B▲ 0% |
Equity Growth % | 34.91% | -11.69% | 37.28% | 23.71% | -9.32% | -44.9% | 27.89% | 18.92% | 24.25% | 80.81% |
Shareholders Equity | 9.57B | 8.45B | 11.6B | 14.35B | 13.01B | 7.08B | 9.08B | 10.82B | 13.46B | 13.29B |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 90M | 90M | 90M | 90M | 90M |
Retained Earnings | 6.74B | 7.28B | 7.95B | 8.15B | 8.56B | 8.17B | 8.8B | 9.26B | 10.15B | 10.38B |
Common Stock | 791K | 791K | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M |
Accumulated OCI | 2.06B | 636.76M | 3.14B | 5.36B | 3.64B | -1.87B | -369M | 849M | 2.68B | 2.31B |
Return on Equity (ROE) | 21.87% | 7.95% | 8.68% | 3.2% | 8.55% | 5.12% | 11.04% | 7.14% | 9.67% | 9.4% |
Return on Assets (ROA) | 3.21% | 1.15% | 1.23% | 0.51% | 1.32% | 0.58% | 0.99% | 0.66% | 0.86% | 0.81% |
Equity / Assets | 15.81% | 13.09% | 15.12% | 16.95% | 14.12% | 8.45% | 9.39% | 9.19% | 8.65% | 8.16% |
Debt / Equity | 0.37x | 0.41x | 0.31x | 0.28x | 0.30x | 0.55x | 0.48x | 0.46x | 0.42x | 0.46x |
Book Value per Share | 145.54 | 129.82 | 181.60 | 218.12 | 190.54 | 105.92 | 136.68 | 163.02 | 203.07 | 200.57 |
Tangible BV per Share | 142.42 | 129.21 | 181.08 | 217.74 | 190.37 | 105.72 | 136.51 | 162.90 | 202.98 | 200.57 |
Reinsurance Group of America, Incorporated (RGA) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 1.98B | 1.58B | 2.31B | 3.32B | 4.18B | 1.34B | 4.04B | 9.37B | 4.09B | 5.54B |
Operating CF Growth % | 35.24% | -20.24% | 45.91% | 44% | 25.89% | -67.89% | 201.12% | 131.7% | -56.34% | 31.88% |
Operating CF / Revenue % | 15.84% | 12.28% | 16.25% | 22.78% | 26.04% | 8.46% | 21.99% | 42.51% | 17.95% | 22.51% |
Net Income | 1.82B | 715.84M | 870M | 415M | 617M | 517M | 902M | 717M | 1.18B | 1.23B |
Depreciation & Amortization | 53M | 45.13M | 49M | 3M | -11M | 38M | 41M | 46M | 43M | 0 |
Stock-Based Compensation | 0 | 0 | 39M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes | 0 | 76.51M | 0 | -16M | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Cash Items | -249.14M | 5.38M | -31M | -62M | -731M | 346M | -34M | 343M | -301M | 4.31B |
Working Capital Changes | 356.27M | 738.26M | 1.38B | 2.98B | 4.31B | 442M | 3.13B | 8.26B | 3.17B | 0 |
Cash from Investing | -1.61B | -636.55M | -2.64B | -2.68B | -4.63B | -5.69B | -4.07B | -12.54B | -12.09B | -14.1B |
Capital Expenditures | -44.21M | -28.89M | -34M | -28M | -19M | -25M | 0 | 0 | 0 | 0 |
Acquisitions | 0 | -31.44M | 4M | -173M | -287M | 17M | -77M | -320M | 0 | 0 |
Purchase of Investments | -8.94B | -10.1B | -16.28B | -10.26B | -18.28B | -17.07B | -13.25B | -41.69B | -43.67B | -48.52B |
Sale/Maturity of Investments | 8.04B | 10.14B | 14.11B | 7.67B | 13.83B | 11.47B | 8.55B | 30.49B | 32.19B | 35.05B |
Other Investing | -657.07M | -615.69M | -442M | 115M | 129M | -77M | 711M | -1.03B | -613M | -628M |
Cash from Financing | -324.62M | -321.97M | -121M | 1.25B | 20M | 4.44B | 78M | 3.66B | 8.8B | 8.4B |
Dividends Paid | -117.29M | -140.11M | -163M | -182M | -194M | -205M | -219M | -229M | -240M | -242M |
Share Repurchases | -44M | -299.68M | -101M | -163M | -99M | -81M | -227M | -27M | -174M | -230M |
Stock Issued | 0 | 0 | 0 | 481M | 0 | 0 | 0 | 0 | 4M | 9M |
Debt Issuance (Net) | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | -2M |
Other Financing | 207.67M | 217.14M | 38M | 737M | 430M | 4.62B | 62M | 3.31B | 8.55B | 8.49B |
Net Change in Cash | 102.81M▲ 0% | 586.21M▲ 470.2% | -441M▼ 175.2% | 1.96B▲ 544.2% | -460M▼ 123.5% | -21M▲ 95.4% | 43M▲ 304.8% | 356M▲ 727.9% | 842M▲ 136.5% | -158M▲ 0% |
Exchange Rate Effect | 52.69M | -36.39M | 11M | 63M | -34M | -112M | -13M | -130M | 47M | 6M |
Cash at Beginning | 1.2B | 1.3B | 1.89B | 1.45B | 3.41B | 2.95B | 2.93B | 2.97B | 3.33B | 4.17B |
Cash at End | 1.3B | 1.89B | 1.45B | 3.41B | 2.95B | 2.93B | 2.97B | 3.33B | 4.17B | 4.99B |
Free Cash Flow | 1.94B▲ 0% | 1.55B▼ 19.9% | 2.27B▲ 46.4% | 3.29B▲ 44.9% | 4.16B▲ 26.4% | 1.32B▼ 68.3% | 4.04B▲ 206.8% | 9.37B▲ 131.7% | 4.09B▼ 56.3% | 5.54B▲ 0% |
FCF Growth % | 36.38% | -19.91% | 46.43% | 44.92% | 26.38% | -68.34% | 206.83% | 131.7% | -56.34% | 9.32% |
FCF Margin % | 15.48% | 12.06% | 16.01% | 22.59% | 25.92% | 8.3% | 21.99% | 42.51% | 17.95% | 22.51% |
FCF per Share | 29.48 | 23.85 | 35.58 | 50.06 | 60.95 | 19.47 | 60.27 | 140.06 | 61.31 | 82.94 |
Reinsurance Group of America, Incorporated (RGA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Combined Ratio | 90.87% | 93.43% | 92.03% | 96.21% | 91.38% | 95.48% | 93.69% | 95.55% | 93.24% | 93.45% |
Medical Cost Ratio | 83.8% | 85.95% | 85.2% | 89.41% | 88.46% | 90.11% | 87.33% | 88.71% | 74.6% | 79.67% |
Return on Equity (ROE) | 21.87% | 7.95% | 8.68% | 3.2% | 8.55% | 5.12% | 11.04% | 7.14% | 9.67% | 9.4% |
Return on Assets (ROA) | 3.21% | 1.15% | 1.23% | 0.51% | 1.32% | 0.58% | 0.99% | 0.66% | 0.86% | 0.81% |
Equity / Assets | 15.81% | 13.09% | 15.12% | 16.95% | 14.12% | 8.45% | 9.39% | 9.19% | 8.65% | 8.16% |
Book Value / Share | 145.54 | 129.82 | 181.6 | 218.12 | 190.54 | 105.92 | 136.68 | 163.02 | 203.07 | 200.57 |
Debt / Equity | 0.37x | 0.41x | 0.31x | 0.28x | 0.30x | 0.55x | 0.48x | 0.46x | 0.42x | 0.46x |
Revenue Growth | 8.63% | 2.88% | 10.27% | 2.71% | 10.13% | -1.13% | 15.82% | 19.85% | 3.39% | 17.29% |
Reinsurance Group of America, Incorporated (RGA) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 7, 2026·SEC
May 1, 2026·SEC
Mar 20, 2026·SEC
Reinsurance Group of America, Incorporated (RGA) stock FAQ — growth, dividends, profitability & financials explained
Reinsurance Group of America, Incorporated (RGA) grew revenue by 3.4% over the past year. Growth has been modest.
Yes, Reinsurance Group of America, Incorporated (RGA) is profitable, generating $1.23B in net income for fiscal year 2025 (5.2% net margin).
Yes, Reinsurance Group of America, Incorporated (RGA) pays a dividend with a yield of 1.71%. This makes it attractive for income-focused investors.
Reinsurance Group of America, Incorporated (RGA) has a return on equity (ROE) of 9.7%. This is below average, suggesting room for improvement.
Reinsurance Group of America, Incorporated (RGA) has a combined ratio of 93.2%. A ratio below 100% indicates underwriting profitability.